Gate2Brain was honored to participate in the Pediatric Diffuse Midline Glioma (DMG) International Meeting, hosted at the SJD Pediatric Cancer Center in Barcelona. This gathering united experts from Spain and the Pacific Pediatric Neuro Oncology Consortium (PNOC), encompassing both physicians and scientists specializing in the field of DMG.
The primary goal of this event was to enhance our current comprehension of DMG and pinpoint vulnerabilities within these tumors, with the ultimate objective of developing more effective therapies.
During the meeting, Gate2Brain had the privilege of contributing to the session focused on DMG Research and Clinical Trials. We presented our insights on “Gate2Brain Technology: From Discovery to Application in Pediatric Brain Tumors with an Intact Blood-Brain Barrier, such as DMGs.”
This experience offered a unique opportunity to stay abreast of the latest developments related to diffuse midline glioma and the ongoing initiatives dedicated to improving the prognosis of children and adolescents suffering from this devastating brain cancer.
We extend our heartfelt gratitude to Hospital Sant Joan de Déu Barcelona for this outstanding and purposeful event.